Sertraline versus imipramine to prevent relapse in chronic depression Academic Article Article uri icon

Overview

MeSH Major

  • Bipolar Disorder
  • Models, Statistical
  • Practice Guidelines as Topic

abstract

  • Most chronic depression patients who remit with 12 weeks of sertraline or imipramine treatment maintain remission during 16 weeks of continuation treatment. Most patients with a satisfactory therapeutic response (partial remission) after 12 weeks of treatment maintain it or further improve. Patients treated with imipramine experienced more side effects, but both drugs were well tolerated.

publication date

  • May 17, 2001

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1016/S0165-0327(00)00272-X

PubMed ID

  • 11426506

Additional Document Info

start page

  • 27

end page

  • 36

volume

  • 65

number

  • 1